Background Team-based learning (TBL) is increasingly being utilized across medical fields by engaging students in small group discussions. The readiness assurance test (RAT) is an essential feature that differentiates TBL from problem-based learning (PBL) activity sequences. No publication has discussed differences in the RAT in TBL in medical schools. The purpose of this meta-analysis study was to examine the performance of learners in terms of group RAT (GRAT) and individual RAT (IRAT) scores in TBL for students of healthcare professions. Methods Databases, including PubMed and Cochrane were searched using several terms. We assessed the quality of included studies and conducted a meta-analysis. Results In total, 11 studies with 1575 participants were identified. Quality assessment scores of these studies ranged 4 ~ 7. Mean GRAT scores were significantly higher than mean IRAT scores (standardized mean difference (SMD) = 2.027, 95% confidence interval (CI) = 1.657 ~ 2.486, p heterogeneity < 0.001). Although the test of subgroup differences was insignificant ( p = 0.113), the nursing-only subgroup showed much better performance in the GRAT than the IRAT (SMD = 2.3CI: 95% CI = 2.0 ~ 2.6, I 2 = 48.77%) compared to the others subgroup which included students from different majors. The subgroup analysis explained the heterogeneity in the overall analysis. Because of inadequate information from these 11 studies, a meta-regression could not explore the source of heterogeneity in terms of the mean age, duration of the intervention, preparation time before the RAT, and previous TBL experienced by students. Conclusions Students achieved significantly higher scores for the GRAT than for the IRAT, especially the group which only included nursing students, which implies excellent collaboration in the group of nursing students.
Skin cancer as the most common cancer diagnosis tend to be increasing. This condition is a particularly significant issue in developed countries. This study aimed to describe the clinical features, histopathological features, complications, and early surgical treatment outcomes of skin cancer in CanTho Oncology Hospital from 2014 to 2015. This descriptive prospective study involved all patients with non-melanoma skin cancer that were examined and treated at Can Tho Oncology Hospital from July 2014 to March 2015. There were 78 cases selected. Skin cancer was found to be more common among older patients. The prevalence of basal cell carcinoma was found higher than squamous cell carcinoma with percentage worth 76.9% and 23.1% respectively. Worth 73.1% of all the patients in the study underwent surgery with wide resection and reconstruction. In this study, most patients were the elderly. The basal cell carcinoma was the most common. The main treatment was surgery with wide resection and reconstruction. The complication was rare 1.3% with skin flap necrosis Penelitian pada Fitur Klinis, Histopatologis dan Hasil Evaluasi PengobatanKanker di Rumah Sakit Onkologi Can ThoKanker kulit, diagnosis kanker paling umum, cenderung mengalami peningkatan. Kondisi ini secara khusus merupakan isu penting di negara-negara maju. Penelitian ini bertujuan untuk mendeskripsikan fitur klinis, fitur hispatologis, komplikasi dan hasil pengobatan bedah awal kanker kulit di Rumah Sakit Onkologi Can Tho dari tahun 2014 sampai 2015. Penelitian deskriptif prospektif ini melibatkan seluruh pasien dengan kanker kulit nonmelanoma yang diuji dan diobati di Rumah Sakit Onkologi Can Tho dari Juli 2014 sampai Maret 2015. Terdapat 78 kasus terpilih. Kanker kulit ditemukan lebih umum pada pasien yang lebih tua. Prevalensi karsinoma sel basal ditemukan lebih tinggi dibandingkan karsinoma sel skuamosa dengan persentase masing-masing 76,9% dan 23,1%. Sebesar 73,1% dari seluruh pasien dalam penelitian ini menjalani bedah dengan rekonstruksi dan reseksi yang lebar. Dalam penelitian ini, sebagian besar pasien adalah lanjut usia. Karsinoma sel basal adalah yang paling umum. Pengobatan utama adalah bedah dengan rekonstruksi dan reseksi yang lebar. Komplikasi jarang terjadi 1,3% dengan nekrosis lipatan kulit.
Results: Overall, 14,720 patients were identified with the diagnosis of LGG. Median age at diagnosis was 43 years. Forty-one percent were treated at community centers with 59% at Academic/Integrated cancer programs. Eighty-six percent were white, 65% had private insurance, 34% resided in areas with median income <$48,000, 41% in areas where >13% had not graduated high school. On multivariate analysis, those with private insurance were more likely to undergo surgery (HRZ1.38, p<0.001), radiation therapy (RT) (HRZ1.19, p<0.001), and chemotherapy (HRZ1.33, p<0.001). Those <20 miles to the reporting facility were more likely to receive RT (HRZ1.50, p<0.001) and chemotherapy (HRZ1.14, pZ0.002). Those treated at a community center were less likely to undergo surgery (HRZ0.65, p<0.001) and more likely to receive RT (HRZ1.24, p<0.001). Patients who were white (HRZ1.23-1.31, p<0.001), had a higher education (HRZ1.14, p<0.001), or treated at a later year (HRZ1.19-1.21, p<0.001) were more likely to receive chemotherapy. Astrocytoma/mixed histology was more likely to undergo RT (HRZ1.98-2.23, p<0.001), while oligodendroglioma/mixed histology were more likely to receive surgery (HRZ3.03, p<0.001) and chemotherapy (HRZ1.12-1.13, p<0.001). There was no significant difference in time from diagnosis to any treatment based on sex, race, income, education, and insurance except a younger age which was significantly associated with a reduced time to treatment among all modalities. Conclusion: While this analysis does not control for all treatment related factors, it emphasizes the importance of societal factors in the treatment selection for LGG patients. Further investigation is required in order to identify interventions which will improve and standardize equal access to care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.